{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:21:50Z","timestamp":1787440910778,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100018525","name":"Key Research and Development Program of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018525","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72574158"],"award-info":[{"award-number":["72574158"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2024YFFK0082"],"award-info":[{"award-number":["2024YFFK0082"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijantimicag.2026.107872","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:59:44Z","timestamp":1780329584000},"page":"107872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The efficacy and safety of inhaled antibiotics in the treatment of lower respiratory tract infection: An updated meta-analysis and evidence map of systematic reviews"],"prefix":"10.1016","volume":"67","author":[{"given":"Yuanhui","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunsong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107872_bib0001","unstructured":"World Health Organization. The top 10 causes of death. Available online: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death (accessed 21.04.25)."},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0002","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/17476348.2019.1555040","article-title":"Epidemiology of lower respiratory tract infections in adults","volume":"13","author":"Feldman","year":"2019","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0003","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/CMR.00101-15","article-title":"Inhaled antibiotics for gram-negative respiratory infections","volume":"29","author":"Wenzler","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0004","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejpb.2019.09.002","article-title":"Challenges and strategies in drug delivery systems for treatment of pulmonary infections","volume":"144","author":"Ho","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0005","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MCP.0000000000000952","article-title":"Advances in inhaled antibiotics for management of respiratory tract infections","volume":"29","author":"Riveiro","year":"2023","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0006","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3390\/ijms18051062","article-title":"Inhaled antibiotic therapy in chronic respiratory diseases","volume":"18","author":"Maselli","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0007","first-page":"338","article-title":"Cystic fibrosis: recent insights into inhaled antibiotic treatment and future perspectives","volume":"10","author":"Taccetti","year":"2021","journal-title":"Antibiot (Basel Switz)"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0008","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jconrel.2020.07.002","article-title":"Scope and limitations on aerosol drug delivery for the treatment of infectious respiratory diseases","volume":"325","author":"Douafer","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0009","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcrc.2021.06.004","article-title":"Effectiveness and safety of adjunctive inhaled antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials","volume":"65","author":"Tang","year":"2021","journal-title":"J Crit Care"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejim.2021.04.009","article-title":"Inhaled antibiotics for treatment of adults with non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis","volume":"90","author":"Tejada","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0011","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s40262-015-0250-x","article-title":"Clinical pharmacokinetics of inhaled antimicrobials","volume":"54","author":"Stockmann","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0012","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.addr.2015.03.002","article-title":"Pharmacokinetic and pharmacodynamic implications in inhalable antimicrobial therapy","volume":"85","author":"Mukker","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0013","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.chest.2024.01.045","article-title":"The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: updated systematic review and meta-analysis","volume":"166","author":"Cordeiro","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0014","article-title":"Antibiotic treatment of pulmonary infections: an umbrella review and evidence map","volume":"12","author":"Wu","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107324","article-title":"The preventive effect of inhaled antibiotic against ventilator-associated pneumonia: a systematic review and meta-analysis","volume":"64","author":"Hsu","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0016","article-title":"Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement","volume":"378","author":"Gates","year":"2022","journal-title":"BMJ (Clin Res ed)"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0017","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jclinepi.2015.06.005","article-title":"ROBIS: A new tool to assess risk of bias in systematic reviews was developed","volume":"69","author":"Whiting","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0018","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0019","article-title":"Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis","volume":"1","author":"Hurley","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0020","article-title":"Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis","volume":"6","author":"Langton Hewer","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0021","article-title":"Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis","volume":"11","author":"Smith","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0022","article-title":"Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis","volume":"8","author":"Smith","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0023","article-title":"Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis","volume":"12","author":"Lo","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0024","article-title":"Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis","volume":"12","author":"Frost","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0025","article-title":"Oral anti-pseudomonal antibiotics for cystic fibrosis","volume":"7","author":"Remmington","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0026","article-title":"Intermittent prophylactic antibiotics for bronchiectasis","volume":"1","author":"Spencer","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106283","article-title":"Inhaled tobramycin for chronic infection with pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis","volume":"176","author":"Sangiovanni","year":"2021","journal-title":"Respir Med"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0028","doi-asserted-by":"crossref","DOI":"10.1177\/1753466620936866","article-title":"Inhaled antibiotics therapy for stable non-cystic fibrosis bronchiectasis: a meta-analysis","volume":"14","author":"Xu","year":"2020","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0029","doi-asserted-by":"crossref","DOI":"10.1177\/1753466619875930","article-title":"Efficacy of inhaled ciprofloxacin agents for the treatment of bronchiectasis: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Lim","year":"2019","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0030","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/bmjebm-2018-110893","article-title":"Prevention of exacerbations in patients with stable non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis of pharmacological and non-pharmacological therapies","volume":"23","author":"Abu Dabrh","year":"2018","journal-title":"BMJ Evid-Based Med"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0031","article-title":"Dual antibiotics for bronchiectasis","volume":"6","author":"Felix","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0032","doi-asserted-by":"crossref","first-page":"491","DOI":"10.31083\/ph.2016.6590","article-title":"Inhaled antibiotics in non-cystic fibrosis bronchiectasis: a meta-analysis","volume":"71","author":"Xu","year":"2016","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0033","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s13054-024-05159-9","article-title":"Inhaled antibiotics for treating pneumonia in invasively ventilated patients in intensive care unit: a meta-analysis of randomized clinical trials with trial sequential analysis","volume":"28","author":"Sella","year":"2024","journal-title":"Crit Care (Lond Engl)"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2023.154315","article-title":"Nebulized colistin as the adjunctive treatment for ventilator-associated pneumonia: a systematic review and meta-analysis","volume":"77","author":"Zhang","year":"2023","journal-title":"J Crit Care"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0035","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1038\/s41598-021-86342-8","article-title":"Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Qin","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0036","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/ALN.0000000000001570","article-title":"Nebulization of antiinfective agents in invasively mechanically ventilated adults: a systematic review and meta-analysis","volume":"126","author":"Sol\u00e9-Lleonart","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0037","first-page":"l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ (Clin Res ed)"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0038","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0039","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/jamp.2021.0023","article-title":"The unfulfilled promise of inhaled therapy in ventilator-associated infections: where do we go from here?","volume":"35","author":"Palmer","year":"2022","journal-title":"J Aerosol med Pulm Drug deliv"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0040","first-page":"299","article-title":"Eradication therapy against pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","volume":"90","author":"Orriols","year":"2015","journal-title":"Respir; int Rev Thorac Dis"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0041","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1086\/314727","article-title":"Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis","volume":"179","author":"Burns","year":"1999","journal-title":"J Infect Dis"},{"issue":"Pt B","key":"10.1016\/j.ijantimicag.2026.107872_bib0042","article-title":"Significant higher airborne antibiotic resistance genes and the associated inhalation risk in the indoor than the outdoor","volume":"268","author":"Zhao","year":"2021","journal-title":"Environ Pollut (Barking Essex : 1987)"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0043","first-page":"217","article-title":"Antibiotic resistance in patients with cystic fibrosis: past, present, and future","volume":"12","author":"Perikleous","year":"2023","journal-title":"Antibiot (Basel Switz)"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0044","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jcf.2015.02.005","article-title":"Cystic fibrosis microbiology: Advances in antimicrobial therapy","volume":"14","author":"Waters","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0045","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1080\/13543776.2020.1839415","article-title":"Micro\/nanosystems and biomaterials for controlled delivery of antimicrobial and anti-biofilm agents","volume":"30","author":"Bianchera","year":"2020","journal-title":"Expert opin Ther Pat"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0046","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s40265-020-01359-z","article-title":"Inhaled liposomal antimicrobial delivery in lung infections","volume":"80","author":"Bassetti","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0047","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3389\/fmicb.2020.01480","article-title":"Microbial distribution and antibiotic susceptibility of lower respiratory tract infections patients from pediatric ward, adult respiratory ward, and respiratory intensive care unit","volume":"11","author":"Duan","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0048","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s13054-017-1916-6","article-title":"Antimicrobials for the treatment of drug-resistant Acinetobacter baumannii pneumonia in critically ill patients: a systemic review and Bayesian network meta-analysis","volume":"21","author":"Jung","year":"2017","journal-title":"Crit Care (Lond Engl)"},{"key":"10.1016\/j.ijantimicag.2026.107872_bib0049","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","article-title":"Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis","volume":"18","author":"Schuetz","year":"2018","journal-title":"Lancet Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926001603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926001603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:41:12Z","timestamp":1787438472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926001603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0924857926001603"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107872","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of inhaled antibiotics in the treatment of lower respiratory tract infection: An updated meta-analysis and evidence map of systematic reviews","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107872","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107872"}}